Eledon reports Phase 2 kidney transplant drug data at ATC

June 22, 2026 7:00 AM

Eledon Pharmaceuticals (Nasdaq: ELDN) presented long-term data from its Phase 2 BESTOW clinical ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found